Supporting data for positron emission tomography-based risk modelling using a fixed-instead of a relative thresholding method for total metabolic tumor volume determination.

Agreement DLBCL Fixed thresholding method PETAL trial Positron emission tomography scanning TMTV determination

Journal

Data in brief
ISSN: 2352-3409
Titre abrégé: Data Brief
Pays: Netherlands
ID NLM: 101654995

Informations de publication

Date de publication:
Feb 2020
Historique:
received: 14 11 2019
accepted: 04 12 2019
entrez: 1 1 2020
pubmed: 1 1 2020
medline: 1 1 2020
Statut: epublish

Résumé

Total metabolic tumor volume (TMTV) was measured in 510 patients with DLBCL participating in the PETAL trial. The present data provide information about the prognostic impact of total metabolic tumor volume using the fixed standardized uptake value (SUV

Identifiants

pubmed: 31890813
doi: 10.1016/j.dib.2019.104976
pii: S2352-3409(19)31331-9
pii: 104976
pmc: PMC6931116
doi:

Types de publication

Journal Article

Langues

eng

Pagination

104976

Informations de copyright

© 2019 The Authors.

Références

Blood. 2014 Dec 18;124(26):3870-9
pubmed: 25359988
Lancet. 1986 Feb 8;1(8476):307-10
pubmed: 2868172
J Clin Oncol. 2018 Jul 10;36(20):2024-2034
pubmed: 29750632
Eur J Cancer. 2020 Jan;124:25-36
pubmed: 31710995

Auteurs

Christine Schmitz (C)

Department of Hematology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Andreas Hüttmann (A)

Department of Hematology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Stefan P Müller (SP)

Department of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Maher Hanoun (M)

Department of Hematology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Ronald Boellaard (R)

Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, the Netherlands.

Marcus Brinkmann (M)

Center for Clinical Trials, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Karl-Heinz Jöckel (KH)

Institute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Ulrich Dührsen (U)

Department of Hematology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Jan Rekowski (J)

Institute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Classifications MeSH